Konji Sebati
Amministratore Delegato presso Innovative Pharmaceutical Association South Africa
Profilo
Konji Sebati is currently the Chief Executive Officer at Innovative Pharmaceutical Association South Africa, Director at MMV Medicines for Malaria Venture, and Trustee at Ivcc.
Previously, from 2015 to 2021, Dr. Sebati was an Independent Non-Executive Director at Resource Generation Ltd.
Posizioni attive di Konji Sebati
Società | Posizione | Inizio |
---|---|---|
Innovative Pharmaceutical Association South Africa | Amministratore Delegato | - |
Ivcc
Ivcc Miscellaneous Commercial ServicesCommercial Services IVCC is a British company that works to prevent vector-borne diseases and combat insecticide resistance. The private company is based in Liverpool, UK. The company achieves this by directly targeting the vector that transmits the disease. The company's Research & Development Portfolio is dedicated to innovative work that prevents vector-borne diseases and tackles insecticide resistance. IVCC was founded in 2005, and the CEO is Nick Hamon. | Direttore/Membro del Consiglio | - |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Konji Sebati
Società | Posizione | Fine |
---|---|---|
RESOURCE GENERATION LIMITED | Direttore/Membro del Consiglio | 15/05/2021 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
Resource Generation Ltd.
Resource Generation Ltd. CoalEnergy Minerals Resource Generation Ltd. engages in the mining, exploration, evaluation, and development of coal resources. It focuses its mining activities in the Boikarabelo Coal Mine in the Waterberg region of South Africa. The firm operates through the Mining Tenements and Mining Development; and Corporate segments. The company was founded on May 4, 1993 and is headquartered in Bryanston, South Africa. | Energy Minerals |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | Commercial Services |
Innovative Pharmaceutical Association South Africa | |
Ivcc
Ivcc Miscellaneous Commercial ServicesCommercial Services IVCC is a British company that works to prevent vector-borne diseases and combat insecticide resistance. The private company is based in Liverpool, UK. The company achieves this by directly targeting the vector that transmits the disease. The company's Research & Development Portfolio is dedicated to innovative work that prevents vector-borne diseases and tackles insecticide resistance. IVCC was founded in 2005, and the CEO is Nick Hamon. | Commercial Services |
- Borsa valori
- Insiders
- Konji Sebati